Professional Documents
Culture Documents
5.3 Immune Reconstitution Inflammatory Syndrome
5.3 Immune Reconstitution Inflammatory Syndrome
Immune Reconstitution
Inflammatory Syndrome (IRIS)
Refer: National Guidelines for HIV Care and Treatment, National AIDS Control
Programme, Care Support, and Treatment services, India: 2021
Source: Samuel A. Shelburne, Martin Montes and Richard J. Hamill Journal of Antimicrobial Chemotherapy,
Source: (2006) 57, 167-170.
• Increased CD4/CD8 cells detect hidden pathogens which were ignored with deficiency
of immunity previously
• This may produce nonspecific symptoms such as fever or in some cases a paradoxical
worsening of pre-existing symptoms of infective or non-infective conditions
• Sarcoid IRIS
• Granulomatous reactions
Answer- B
Source: National Guidelines for HIV Care and Treatment, National AIDS Control Programme, Care Support, and
Treatment services, India: 2021
• The temporal association between the commencement of ART (or change from a
previously failing regimen) and the development of an unusual clinical
phenomenon often provides a strong clue to the diagnosis of IRIS
• Typically, IRIS occurs within 2 to 12 weeks of the initiation of ART, although it may
present later (usually between 6 weeks to 6 months)
Source: National Guidelines for HIV Care and Treatment, National AIDS Control Programme, Care
Support, and Treatment services, 2021
• Heterogeneous
• Atypical symptoms
• Generalised or localised
• Varying severity
• Tuberculosis : 68.8%
• Toxoplasmosis : 6.3%
Manifestation Pts %
Tuberculosis 42 61.8
PCP 10 14.7
Crypto. Meningitis 8 11.8
CMV Retinitis 4 5.9
Toxoplasmosis 2 2.8
PML 1 1.5
Hepatitis 1 1.5
Total IRIS Observed: 68 Total 68 100
Question: Typically, IRIS occurs within _____weeks of ART initiation, though it may
present later, between ______ months after starting ART.
Select the correct option to fill in the blanks.
Answer: D
Source : Devesh J. Dhasmana, Keertan Dheda, Pernille Ravn, Robert J. Wilkinson and Graeme Meintjes. IRIS in HIV-Infected
Patients Receiving Antiretroviral Therapy Pathogenesis, Clinical Manifestations & Management. Drugs, 2008; 68(2):191-208
o Cervical lymphadenopathy,
o Intra-thoracic lymphadenopathy
Images Courtesy:
GHTM-ITECH
Fellowship,
Tambaram, Chennai
Images
Courtesy
GHTM,
Tambaram,
Chennai
o Presented with cough, grade 4 dyspnoea and tachypnoea on 16th May, 2006
(CD4: 162 cells)
o Diagnosis: IRIS-PCP
Case and Image Source: GHTM – I-TECH Fellowship Program, Tambaram, Chennai
Image Source: Graeme Meintjes, HIV service, GF Jooste Hospital, Department of Medicine,
UCT
• Treatment Failure
o Observation
o Local therapy such as minor surgical procedures for lymph node abscesses
Answer: B
Lower CD4 counts (below 100 cells/mm3) at ART initiation
• Earlier HIV diagnosis and initiation of ART before decline of CD4 below 200 cells/mm3;
• Improved screening for OIs before ART, especially TB, Cryptococcus, CMV and
• Timing of ART in people with OIs requires balancing a greater risk of IRIS after early
initiation against continuing high mortality if ART is delayed
• HIV infected persons who come late in their disease course, with low CD4 counts
(advanced stage of immunodeficiency) are at the greater risk of IRIS
• IRIS is less likely to occur when ART is initiated early (when patient has high CD4
count)
• Clinicians need to consider IRIS as one of the diagnostic options, whenever PLHIV
develop various clinical manifestations after ART initiation